FDA.reportPublic FDA data

3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen Injector [Soliqua]

RxCUI
1859000
RxNorm name
3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen Injector [Soliqua]
Display name
3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen Injector [Soliqua]
Full name
3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen Injector [Soliqua]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
208673Soliqua 100/33insulin glargine and lixisenatide351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
4bba538b-cf7c-4310-ae8f-cb711ed21bcc3 ML insulin glargine 100 UNT/ML / lixisenatide 0.033 MG/ML Pen Injector [Soliqua]SBD25These highlights do not include all the information needed to use SOLIQUA 100/33 safely and effectively . See full prescribing information for SOLIQUA 100/33. SOLIQUA ® 100/33 (insulin glargine and lixisenatide) injection, for subcutaneous use Initial U.S. Approval: 201620260318
4bba538b-cf7c-4310-ae8f-cb711ed21bccSoliqua 100/33 in 3 ML Pen InjectorPSN25These highlights do not include all the information needed to use SOLIQUA 100/33 safely and effectively . See full prescribing information for SOLIQUA 100/33. SOLIQUA ® 100/33 (insulin glargine and lixisenatide) injection, for subcutaneous use Initial U.S. Approval: 201620260318
4bba538b-cf7c-4310-ae8f-cb711ed21bccSoliqua 100/33 per 3 ML Pen InjectorSY25These highlights do not include all the information needed to use SOLIQUA 100/33 safely and effectively . See full prescribing information for SOLIQUA 100/33. SOLIQUA ® 100/33 (insulin glargine and lixisenatide) injection, for subcutaneous use Initial U.S. Approval: 201620260318